Targeting the NF‐κB pathway in estrogen receptor negative MDA‐MB‐231 breast cancer cells using small inhibitory RNAs

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Cellular Biochemistry

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcb.20789PMID 16408291
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a (PII:S0092-8674(04)00302-2)

  2007cited by this paper
• RNAi versus small molecules: different mechanisms and specificities can lead to different outcomes.

  2005cited by this paper
• Cancer genes and the pathways they control

  2004cited by this paper
• IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

  2004cited by this paper
• Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{kappa}B at serine 536 is mediated by multiple protein kinases including I{kappa}B kinase (IKK)-{alpha}, IKK{beta}, IKK{epsilon}, TRAF family member-associated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to

  2004cited by this paper
• NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis.

  2004cited by this paper
• Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target.

  2004cited by this paper
• Nuclear factor-κB: a friend or a foe in cancer?

  2004cited by this paper
• NF-κB activation in human breast cancer specimens and its role in cell proliferation and apoptosis

  2004cited by this paper
• Blocking anti‐apoptosis as a strategy for cancer chemotherapy: NF‐κB as a target

  2004cited by this paper
• NF-κB in cancer: a marked target

  2003cited by this paper
• CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response

  2003cited by this paper
• A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.

  2003cited by this paper
• Phosphoinositide 3-kinase activity leads to silica-induced NF-κB activation through interacting with tyrosine-phosphorylated IκB-α and contributing to tyrosine phosphorylation of p65 NF-κB

  2003cited by this paper
• Defects in the apoptotic machinery of cancer cells: role in drug resistance.

  2003cited by this paper
• The protein kinase C inhibitor Gö6976 is a potent inhibitor of DNA damage-induced S and G2 cell cycle checkpoints.

  2003cited by this paper
• TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway.

  2003cited by this paper
• Phosphoinositide 3-kinase activity leads to silica-induced NF-kappaB activation through interacting with tyrosine-phosphorylated I(kappa)B-alpha and contributing to tyrosine phosphorylation of p65 NF-kappaB.

  2003cited by this paper
• A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts*

  2003cited by this paper
• IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy

  2003cited by this paper
• TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway

  2003cited by this paper
• CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response.

  2003cited by this paper
• NF-kappaB in cancer: a marked target.

  2003influential reference
• NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach.

  2003cited by this paper
• RNA interference

  2002cited by this paper
• Lymphotoxin-beta receptor mediates NEMO-independent NF-kappaB activation.

  2002cited by this paper
• Cell cycle and death control: long live Forkheads.

  2002cited by this paper
• Not just research tools—proteasome inhibitors offer therapeutic promise

  2002cited by this paper
• Upstream signal transduction of NF-kappaB activation.

  2002cited by this paper
• Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF‐κB

  2002cited by this paper
• NF-kappaB and breast cancer.

  2002cited by this paper
• NF-?B and breast cancer

  2002cited by this paper
• Lymphotoxin‐β receptor mediates NEMO‐independent NF‐κB activation

  2002cited by this paper
• Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.

  2001cited by this paper
• Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.

  2001cited by this paper
• The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.

  2001cited by this paper
• The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers

  2001cited by this paper
• Specificity and mechanism of action of some commonly used protein kinase inhibitors.

  2000cited by this paper
• NF-kappaB activation.

  2000cited by this paper
• Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells

  2000cited by this paper
• RNA Interference

  2000cited by this paper
• Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.

  2000cited by this paper
• The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation.

  1999cited by this paper
• Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome.

  1999cited by this paper
• Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis.

  1998cited by this paper
• Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

  1997cited by this paper
• Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

  1997cited by this paper
• Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation

  1996cited by this paper
• New colorimetric cytotoxicity assay for anticancer-drug screening.

  1990cited by this paper
• Insight Review Articles

  year unknowncited by this paper

• Camel Urine Promotes Sensitization to Doxorubicin by Inhibiting Epithelial-Mesenchymal Transition and Modulating NF-κB-Snail Signaling Pathway in Breast Cancer Cells

  2021cites this paper
• Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy.

  2020cites this paper
• SMARCAD1 in Breast Cancer Progression

  2018cites this paper
• FK-3000 isolated from Stephania delavayi Diels. inhibits MDA-MB-231 cell proliferation by decreasing NF-κB phosphorylation and COX-2 expression

  2015cites this paper
• Trichothecin Induces Cell Death in NF-κB Constitutively Activated Human Cancer Cells via Inhibition of IKKβ Phosphorylation

  2013cites this paper
• CyclinD1 protein plays different roles in modulating chemoresponses in MCF7 and MDA-MB231 cells

  2012cites this paper
• Citrus Limonin Lacks the Antichemotherapeutic Effect in Human Models of Breast Cancer

  2012cites this paper
• Activation of brain endothelium by soluble aggregates of the amyloid-β protein involves nuclear factor-κB.

  2011cites this paper
• Stephania delavayi Diels. inhibits breast carcinoma proliferation through the p38 MAPK/NF-κB/COX-2 pathway.

  2011cites this paper
• Annexin-1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-κB: implication in breast cancer metastasis

  2011cites this paper
• PRKC-ζ Expression Promotes the Aggressive Phenotype of Human Prostate Cancer Cells and Is a Novel Target for Therapeutic Intervention.

  2010cites this paper
• p65/RelA Modulates BECN1 Transcription and Autophagy

  2009cites this paper
• Sulindac induces apoptotic cell death in susceptible human breast cancer cells through, at least in part, inhibition of IKKβ

  2009cites this paper
• Wilms' Tumor 1 Suppressor Gene Mediates Antiestrogen Resistance via Down-Regulation of Estrogen Receptor-α Expression in Breast Cancer Cells

  2008cites this paper
• The vitamin D receptor‐mediated activation of phosphatidylinositol 3‐kinase (PI3Kα) plays a role in the 1α,25‐dihydroxyvitamin D3‐stimulated increase in steroid sulphatase activity in myeloid leukaemic cell lines

  2008cites this paper
• Indole-3-carbinol-induced modulation of NF-κB signalling is breast cancer cell-specific and does not correlate with cell death

  2008cites this paper
• Expression of microRNA-146 suppresses NF-κB activity with reduction of metastatic potential in breast cancer cells

  2008cites this paper
• Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells.

  2008cites this paper
• Down-Regulation of Pro-Apoptotic Genes is an Early Event in the Progression of Malignant Melanoma

  2007cites this paper